Preparing for an FDA inspection can feel overwhelming, especially when the stakes are high for medical device companies. Our team understands the pressure operations leaders face to ensure compliance and maintain smooth operations. With the right preparation, an FDA inspection can become an opportunity to demonstrate your commitment to quality and regulatory standards rather than a source of stress. In this guide, we will walk through practical steps and insights to help you

Navigating the FDA submission process for medical devices can be complex and time-consuming. With evolving regulatory requirements, it is essential to adopt efficient strategies that streamline submissions and improve approval chances. One such strategy is leveraging eSTAR consulting for FDA submissions. Our team has seen firsthand how preparing for eSTAR readiness can transform the submission experience, reduce errors, and accelerate time to market. Understanding eSTAR Consu

Post-market surveillance (PMS) is evolving rapidly as regulatory bodies worldwide raise expectations for medical device safety and performance monitoring. The integration of real-world data (RWD), advanced analytics, and harmonized international requirements is reshaping how manufacturers detect safety signals and take corrective actions. This transformation helps ensure patient safety while meeting the demands of regulations such as the European MDR/IVDR and the US FDA. This

Navigating the evolving landscape of medical device regulations can be challenging. Our team has been closely monitoring the recent updates to the FDA Quality Management System Regulation (QMSR). These changes are designed to modernize and harmonize quality system requirements, making compliance more efficient and aligned with global standards. In this post, we will break down the essentials of the new FDA QMSR regulation, explain how it impacts your operations, and share pra

In the fast-paced world of medical device manufacturing, maintaining compliance with regulatory standards is not just a requirement - it is a critical factor that ensures patient safety and product reliability. Our team understands the challenges faced by operations leaders in this industry. One of the most effective ways to enhance compliance is through the implementation of robust Quality Management System (QMS) software tailored specifically for medical devices. This post

In the fast-paced world of medical device manufacturing, maintaining quality and compliance is not just a priority - it is a necessity. Our team understands the challenges faced by operations leaders in this industry. Implementing the right medical device QMS software can streamline processes, ensure regulatory compliance, and ultimately improve product safety and effectiveness. In this post, we will explore some of the top medical device QMS software solutions available toda

Navigating the complexities of FDA regulations and global quality standards is a critical challenge for medical device companies. One of the most important steps in this journey is achieving eSTAR readiness. The Electronic Submission Template And Resource (eSTAR) format is designed to streamline the submission process, but preparing for it requires detailed knowledge and strategic planning. Our team specializes in guiding companies through this process, ensuring they meet all

The FDA updated its Clinical Decision Support (CDS) Software guidance in January 2026, reshaping how developers and healthcare providers approach digital health tools. This update clarifies which CDS software functions are excluded from FDA regulation under the 21st Century Cures Act and which still require oversight. Understanding these changes is crucial for anyone involved in developing, deploying, or using clinical decision support tools. What the Revised Guidance Covers

The FDA updated its General Wellness policy in January 2026, offering clearer guidance on how it regulates low-risk wellness products. This update affects manufacturers and developers of consumer wellness devices and software designed to promote healthy lifestyles without diagnosing or treating diseases. Understanding these changes is crucial for companies to avoid unnecessary regulatory burdens and for consumers to know what products fall under FDA oversight. FDA's updated p